Hello I'm Raiyyan Tahsan
Brand Model and Executive

TC(834).(06).Psychiatry Case No 45. Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention-Deficit/Hyperactivity Disorder (ADHD)

সংজ্ঞা (Definition)

ADHD হলো একটি neurodevelopmental disorder যেখানে শিশুর বা বড় মানুষের মনোযোগ ধরে রাখা, অকারণীয় hyperactivity এবং impulsivity নিয়ন্ত্রণ করা কঠিন হয়।


কারণ / Etiology

ADHD-এর কারণ সম্পূর্ণ বোঝা যায়নি, তবে প্রধান কারণগুলো হলো:

  1. Genetic Factors: পরিবারের মধ্যে ADHD থাকলে ঝুঁকি বেশি।
  2. Neurobiological Factors: মস্তিষ্কের prefrontal cortex, basal ganglia, এবং dopamine ও norepinephrine neurotransmitter এর অস্বাভাবিকতা।
  3. Environmental Factors: ধূমপান, মাতৃর গর্ভকালীন মাদকসেবন, জন্মের আগে বা পরে জটিলতা।
  4. Psychosocial Stressors: পরিবারিক অস্থিরতা বা chronic stress কিছু ক্ষেত্রে exacerbate করতে পারে।

লক্ষণ / Symptoms

ADHD মূলত তিনটি cluster-এ দেখা যায়:

  1. Inattentive Type (মনোযোগে সমস্যা)
    • কাজের সময় মনোযোগ ধরে রাখতে পারছে না
    • ভুলের প্রবণতা বেশি
    • দায়িত্ব সম্পন্ন করতে পারছে না
    • সহজেই distract হয়
  2. Hyperactive-Impulsive Type
    • স্থির থাকতে পারছে না, অনেক চলাফেরা
    • অপ্রয়োজনীয় দৌড়ঝাঁপ বা হাত-পা নাড়াচাড়া
    • অন্যের কথা না শুনে ফুঁসফুঁস করা
    • দ্রুত সিদ্ধান্ত নিয়ে বিপদ তৈরি করা
  3. Combined Type: উপরের দুটি symptom একসাথে থাকে

Clinical Diagnosis / নির্ণয়

DSM-5 Criteria অনুযায়ী ADHD নির্ণয় করা হয়:

  • Symptom কমপক্ষে 6 মাস ধরে থাকতে হবে
  • Age of onset: 12 বছরের আগে
  • Symptom must interfere with social, academic, or occupational functioning
  • Symptom must be present in 2 or more settings (school, home)

Investigation / পরীক্ষা:

  • কোনো রক্ত পরীক্ষা নেই যা ADHD নিশ্চিত করে
  • Diagnosis প্রধানত clinical assessment (history, observation, teacher reports)
  • Rating scales:
    • Conners’ Rating Scale
    • Vanderbilt ADHD Diagnostic Rating Scale
  • Occasionally: neuropsychological testing or EEG/MRI to rule out other disorders

Treatment / Management

1. Pharmacological Treatment (Drug Therapy)

প্রধানত stimulant এবং non-stimulant drugs ব্যবহার করা হয়।


1. Methylphenidate

Tablet 1.Alaradate 10 mg AS A Methylphenidate Hydrochloride AS A CNS stimulant drugs.

 

  • Purpose: Dopamine এবং norepinephrine reuptake inhibit করে মনোযোগ এবং hyperactivity control করে
  • Generic Name: Methylphenidate
  • Dose:
    • Children: 5–20 mg per day, divided dose
    • Adults: 10–60 mg per day, divided dose
  • Duration: Symptom control অনুযায়ী, long-term follow-up প্রয়োজন
  • Side Effects: Insomnia, decreased appetite, headache, abdominal pain, mild increase in BP/HR
  • Interactions: MAO inhibitors (avoid), antihypertensives, anticonvulsants
  • Why Used: Improves attention span, decreases impulsivity, enhances executive function

2. Amphetamine salts (Mixed salts of Amphetamine)

  • Purpose: Stimulate CNS, increase dopamine & norepinephrine
  • Generic Name: Lisdexamfetamine, Dextroamphetamine Not Availavle in Bd, Atomoxetine Hydrochloride Only Available in bd.
  • Capsule 2.Oriham 10 mg AS A Atomoxetine Hydrochloride AS A CNS stimulant drugs.
  • Dose:
    • Children: 5–30 mg per day (Lisdexamfetamine)
    • Adults: 20–60 mg per day
  • Duration: Long-acting preparation: 10–12 hours effect
  • Side Effects: Insomnia, appetite loss, increased BP/HR, anxiety
  • Interactions: MAO inhibitors, acidifying/alkalizing agents
  • Why Used: Long-acting stimulant for attention improvement, behavioral control

  • Atomoxetine (Non-stimulant)

3.Capsule 2.Oriham 10 mg AS A Atomoxetine Hydrochloride AS A CNS stimulant drugs.

  • Purpose: Selective norepinephrine reuptake inhibitor
  • Generic Name: Atomoxetine
  • Dose:
    • Children: 0.5–1.2 mg/kg/day
    • Adults: 40–100 mg/day
  • Duration: Daily, long-term maintenance
  • Side Effects: Nausea, vomiting, liver toxicity (rare), sleep disturbance
  • Interactions: MAO inhibitors, CYP2D6 substrates
  • Why Used: When stimulant contraindicated or anxiety/comorbidities present

  • Guanfacine / Clonidine (Alpha-2 agonist)

Tablet 4.Clonipres 0.1mg AS A Clonidine Hydrochloride AS A Centrally acting antihypertensive drugs (central sympatholytic).

  • Purpose: Reduce hyperactivity and impulsivity
  • Generic Name: Guanfacine / Clonidine
  • Dose:
    • Guanfacine: 1–4 mg/day (children)
    • Clonidine: 0.05–0.4 mg/day
  • Side Effects: Hypotension, sedation, dry mouth
  • Why Used: Behavioral regulation, often adjunct to stimulants

Non-Pharmacological Treatment

  • Behavioral therapy, parent training, school interventions
  • Structured routine, reward system, minimize distractions

Prevention / প্রতিরোধ

  • Genetic prevent impossible, but risk reduction possible:
    1. Healthy pregnancy: avoid alcohol, smoking, illicit drugs
    2. Early identification and behavioral interventions in children
    3. Structured environment and consistent routines
    4. Limit excessive screen time and promote physical activity

সংক্ষিপ্ত Summary

  • ADHD হলো attention deficit + hyperactivity + impulsivity disorder
  • Cause: Genetic + neurobiological + environmental
  • Diagnosis: Clinical + rating scales, DSM-5 criteria
  • Treatment:
    • Stimulants: Methylphenidate, Amphetamines → improve attention & reduce hyperactivity
    • Non-stimulants: Atomoxetine, Guanfacine → alternate/comorbid conditions
  • Prevention: Healthy maternal lifestyle, early intervention, structured environment
Drug (Generic Name)DoseDurationPurpose / UseSide EffectsInteractionsReason for Use
MethylphenidateChildren: 5–20 mg/day, divided Adults: 10–60 mg/daySymptom control, long-termIncreases dopamine & norepinephrine → improves attention, reduces hyperactivityInsomnia, decreased appetite, headache, abdominal pain, mild ↑ BP/HRMAO inhibitors (avoid), antihypertensives, anticonvulsantsFirst-line stimulant for attention & behavioral control
Lisdexamfetamine / DextroamphetamineChildren: 5–30 mg/day (Lisdexamfetamine) Adults: 20–60 mg/dayLong-acting, 10–12 hrs effectCNS stimulant → increases dopamine & norepinephrine → improves focus & reduces impulsivityInsomnia, appetite loss, ↑ BP/HR, anxietyMAO inhibitors, acidifying/alkalizing agentsLong-acting stimulant, useful for school/work hours
AtomoxetineChildren: 0.5–1.2 mg/kg/day Adults: 40–100 mg/dayDaily, maintenanceSelective norepinephrine reuptake inhibitor → improves attention & reduces impulsivityNausea, vomiting, liver toxicity (rare), sleep disturbanceMAO inhibitors, CYP2D6 substratesNon-stimulant option, suitable for anxiety/comorbidity or stimulant intolerance
GuanfacineChildren: 1–4 mg/dayDailyAlpha-2 agonist → reduces hyperactivity & impulsivityHypotension, sedation, dry mouthOther antihypertensives, CNS depressantsAdjunct for behavioral regulation or stimulant combination
ClonidineChildren: 0.05–0.4 mg/dayDailyAlpha-2 agonist → reduces hyperactivity, improves sleepHypotension, sedation, dry mouthAntihypertensives, CNS depressantsUsed adjunctively to control hyperactivity & insomnia

✅ Key Notes:

  • Stimulants (Methylphenidate, Amphetamines) → first-line for attention & hyperactivity.
  • Non-stimulants (Atomoxetine, Guanfacine, Clonidine) → used when stimulants contraindicated or comorbid conditions exist.
  • Monitoring: Blood pressure, heart rate, growth (children), liver function (Atomoxetine).

Reference List

  1. Textbook: Harrison’s Principles of Internal Medicine, 20th Edition, Chapter 363
  2. Guidelines:
    • American Academy of Pediatrics (AAP) Clinical Practice Guideline, 2019
    • NICE Guideline NG87, 2018
  3. Journals:
    • Faraone SV, et al. Nat Rev Dis Primers 2015;1:15020. DOI: 10.1038/nrdp.2015.20
    • Cortese S, et al. Lancet Psychiatry 2018;5:727–738. DOI: 10.1016/S2215-0366(18)30269-4

Md.Rafiqul Islam Lipu,Date:-16-05-2026 Thursaday Time:-09-26-57 Pm

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top